SOPHiA GENETICS (SOPH) Notes Payables (2020 - 2021)
SOPHiA GENETICS's (SOPH) quarterly Notes Payables came in at $2.7 million in Q2 2021, down 5.29% quarter-over-quarter from $2.9 million in Q4 2020.
Analysis
SOPHiA GENETICS (SOPH) Notes Payables (2020 - 2021) Analysis & Trends
SOPHiA GENETICS has disclosed Notes Payables across 2 years of filings, most recently posting $2.7 million for Q2 2021.
- In Q2 2021, Notes Payables changed N/A year-over-year to $2.7 million; the TTM figure through Jun 2021 stood at $2.7 million (changed N/A YoY), while the FY2020 annual figure was $2.9 million, changed N/A from the prior year.
- Notes Payables came in at $2.7 million for Q2 2021 at SOPHiA GENETICS, down from $2.9 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $2.9 million in Q4 2020 to a low of $2.7 million in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 44.53 Bn | 37.29 Bn | 695.95 Mn |
| 2 | Waystar Holding | 4.81 Bn | 4.62 Bn | 221.99 Mn |
| 3 | Doximity | 4.74 Bn | 4.05 Bn | 132.93 Mn |
| 4 | CCC Intelligent Solutions Holdings | 4.41 Bn | 4.30 Bn | 210.64 Mn |
| 5 | EverCommerce | 1.40 Bn | 1.27 Bn | 119.50 Mn |
| 6 | Schrodinger | 1.32 Bn | 904.47 Mn | 32.43 Mn |
| 7 | Certara | 1.21 Bn | 1.03 Bn | 58.15 Mn |
| 8 | GoodRx Holdings | 1.18 Bn | 887.53 Mn | 179.41 Mn |
| 9 | Healthstream | 853.81 Mn | 787.08 Mn | 54.72 Mn |
| 10 | SOPHiA GENETICS | 554.05 Mn | 446.39 Mn | 15.06 Mn |